Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study (Q37383510)
Jump to navigation
Jump to search
scientific article published on 23 December 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study |
scientific article published on 23 December 2010 |
Statements
1 reference
Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study (English)
1 reference
Donna K Arnett
1 reference
John H Eckfeldt
1 reference
Richard Sherva
1 reference
Charles E Ford
1 reference
2 references
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference